Department of Rheumatology, Lincoln County Hospital, Lincoln, UK.
J Rheumatol. 2010 Apr;37(4):783-6. doi: 10.3899/jrheum.091117. Epub 2010 Mar 1.
To conduct a retrospective study to assess whether the degree of thumb involvement differs between primary Raynaud's phenomenon (PRP) and secondary Raynaud's phenomenon (SRP).
Thermography images from all patients attending Salford Royal Hospital and referred for thermography for assessment of RP between 2004 and 2006 were retrospectively reviewed. A distal dorsal difference (DDD) of -1 degrees C or less between the fingertips and dorsum of the hand (fingers cooler) at 23 degrees C was considered clinically relevant. The worse score (the lower score, i.e., the more negative value) from each pair of digits was considered for analysis.
One hundred seventy patients fulfilled the study criteria. DDD at 23 degrees C for the thumbs were significantly higher (digital tips warmer) compared with other digits (p < 0.001) in both PRP and SRP. All digits were significantly warmer in PRP compared to SRP with the exception of the thumbs. The proportion of patients with clinically relevant involvement of thumbs was significantly higher in SRP compared to PRP (p = 0.003) and this difference was more pronounced in the thumbs compared with other digits.
Although the median temperature gradient along the thumb was not significantly different between SRP and PRP, the thumb is more likely to be involved in SRP than in PRP. Thumb involvement is one of a number of clinical indicators that should alert the clinician to the possibility of an underlying connective tissue disease/disorder.
进行回顾性研究,以评估原发性雷诺现象(PRP)和继发性雷诺现象(SRP)之间拇指受累程度是否存在差异。
回顾 2004 年至 2006 年间在索尔福德皇家医院就诊并因 RP 接受热成像评估的所有患者的热成像图像。指尖和手背(手指更冷)之间的 23°C 时的远端背侧差异(DDD)为-1°C 或更低被认为具有临床相关性。分析时考虑了每对数字中较差的评分(即较低的评分,即更负的值)。
170 名患者符合研究标准。在 PRP 和 SRP 中,拇指在 23°C 时的 DDD 明显高于其他手指(p<0.001)。与 SRP 相比,PRP 中所有手指均明显更温暖,除了拇指。与 PRP 相比,SRP 中拇指具有临床相关性受累的患者比例明显更高(p=0.003),与其他手指相比,这种差异在拇指中更为明显。
尽管 SRP 和 PRP 之间拇指的平均温度梯度没有明显差异,但拇指在 SRP 中比在 PRP 中更容易受累。拇指受累是许多临床指标之一,应引起临床医生对潜在结缔组织疾病/障碍的可能性的警惕。